COMPARATIVE CHONDROPROTECTIVE EFFECTS OF INTRA-ARTICULAR HYALURONIC ACID AND TRIAMCINOLONE IN MURINE MODEL OF OSTEOARTHRITIS
Keywords:chondroprotection, osteoarthritis, hyaluronic acid, triamcinolone
AbstractOsteoarthritis is a heterogeneous disease of joints that affects mainly older population. Definitive cure of osteoarthritis is still undiscovered. This study was designed to evaluate and compare the chondroprotective effects of hyaluronic acid and triamcinolone in murine model of osteoarthritis. Methods: This Laboratory based experimental study was carried out in Pharmacology Department, Army Medical College Rawalpindi, from April-June 2019. Osteoarthritis was induced by medial menisectomy and anterior cruciate ligament resectioning of knee joints of twenty-four rats which were then divided into three groups with eight rats in each. Group I, II and III were named control, hyaluronic acid and triamcinolone groups respectively, which were given intra-articular injections of these drugs once weekly for four consecutive weeks and then gait pattern was scored. Animals were sacrificed thereafter and samples were collected for histopathological analysis. Results: Comparison of gait score of control, hyaluronic acid and triamcinolone groups exhibited a p value of <0.01 while intergroup comparison between group I and II, group I and III and group II and III depicted p value of <0.001, 0.016 and 0.003 respectively. Likewise, collective histopathological analysis of the three groups showed p value of <0.01 while intergroup comparison of group I and II, group I and III and group II and III showed p value of <0.001 for all. Conclusion: Comparison of control group with treatment groups proved chondroprotective effects of hyaluronic acid and triamcinolone. Additionally, hyaluronic acid proved to provide better chondroprotection as compared to triamcinolone.
Ghouri A, Conaghan PG. Prospects for therapies in osteoarthritis. Calcif Tissue Int 2020;13(1):1–12.
Woodell‐May JE, Sommerfeld SD. Role of inflammation and the immune system in the progression of osteoarthritis. J Orthop Res 2020;38(2):253–7.
Reginster JY, Veronese N. Highly purified chondroitin sulfate: a literature review on clinical efficacy and pharmacoeconomic aspects in osteoarthritis treatment. Aging Clin Exp Res 2020;7(1):1–11.
Salwowska NM, Bebenek KA, Żądło DA, Wcisło‐Dziadecka DL. Physiochemical properties and application of hyaluronic acid: a systematic review. J Cosm Dermatol 2016;15(4):520–6.
Alves JC, Santos A, Jorge P, Lavrador C, Carreira LM. The intra-articular administration of triamcinolone hexacetonide in the treatment of osteoarthritis. Its effects in a naturally occurring canine osteoarthritis model. PLoS One 2021;16(1):1–20.
Van Heugten AJ, de Boer W, de Vries WS, Markesteijn CM, Vromans H. Development and validation of a stability-indicating HPLC-UV method for the determination of triamcinolone acetonide and its degradation products in an ointment formulation. J Pharm Biomed Analysis 2018;149(5):265–70.
Bapat S, Hubbard D, Munjal A, Hunter M, Fulzele S. Pros and cons of mouse models for studying osteoarthritis. Clin Trans Med 2018;7(1):1–3.
Paglia DN, Kanjilal D, Kadkoy Y, Moskonas S, Wetterstrand C, Lin A, et al. Naproxen treatment inhibits articular cartilage loss in a rat model of osteoarthritis. J Orthop Res 2020;12(1):1–8.
Ma TW, Wen YJ, Song XP, Hu HL, Li Y, Bai H, et al. Puerarin inhibits the development of osteoarthritis through antiinflammatory and antimatrix‐degrading pathways in osteoarthritis‐induced rat model. Phytotherapy Res 2020;12(22):1–15.
Kim SH, Mi-Won SO, Jang SW, Kang MJ, Ma KW. Stable liquid pharmaceutical composition containing HA or its pharmaceutically acceptable salt and hyaluronic acid or its pharmaceutically acceptable salt and the manufacturing method thereof. 2016; p.1–18.
Kim SH, Park KW, Kim JM, Ho MJ, Kim HT, Song SH, et al. Pharmacokinetics and four-week repeated-dose toxicity of hyaluronic acid and ketorolac combination following intra-articular administration in normal rats. Regul Toxicol Pharmacol 2019;102(1):79–89.
Siebelt M, Korthagen N, Wei W, Groen H, Bastiaansen-Jenniskens Y, Müller C, et al. Triamcinolone acetonide activates an anti-inflammatory and folate receptor–positive macrophage that prevents osteophytosis in vivo. Arthritis Res Ther 2015;17(1):352–64.
Kumar A, Bendele AM, Blanks RC, Bodick N. Sustained efficacy of a single intra-articular dose of FX006 in a rat model of repeated localized knee arthritis. Osteoarthritis Cartilage 2015;23(1):151–60.
Aguwa US, Nnamdi OS, Nnabuihe ED, Elizabeth EC, Ogechi A, Nzube OB, et al. Evaluating the Effect of Chloroform Inhalation as a Method of Euthanasia on the Cerebellum and Hippocampus of Adult Wistar Rats. J Adv Med Pharm Sci 2020;27(1):14–25.
Takahashi I, Matsuzaki T, Kuroki H, Hoso M. Joint unloading inhibits articular cartilage degeneration in knee joints of a monosodium iodoacetate-induced rat model of osteoarthritis. Osteoarthritis Cartilage 2019;27(7):1084–93.
Steinberg J, Southam L, Roumeliotis TI, Clark MJ, Jayasuriya RL, Swift D, et al. A molecular quantitative trait locus map for osteoarthritis. Nat Commun 2021;12(1):1309.
Jain KB, Ravikumar P. Recent advances in treatments of cartilage regeneration for knee osteoarthritis. J Drug Del Sci Technol 2020;23(8):1–12.
Hong Z, Gao H, Su Y, Xu B, Wu Z. Effect and mechanism of total alkaloids of strychnine on papain induced rabbit knee osteoarthritis. Biomed Res 2018;29(8):1590–7.
Akman YE, Sukur E, Senel A, Sukur NE, Talu CK, Ozturkmen Y. The comparison of the effects of a novel hydrogel compound and traditional hyaluronate following micro-fracture procedure in a rat full-thickness chondral defect model. Acta Orthop Traumatol Turc 2017;51(4):331–6.
Tamura T, Higuchi Y, Kitamura H, Murao N, Saitoh R, Morikawa T, et al. Novel hyaluronic acid–methotrexate conjugate suppresses joint inflammation in the rat knee: efficacy and safety evaluation in two rat arthritis models. Arthritis Res Ther 2016;18(1):79–89.
Kroin JS, Kc R, Li X, Hamilton JL, Das V, van Wijnen AJ, et al. Intraarticular slow-release triamcinolone acetate reduces allodynia in an experimental mouse knee osteoarthritis model. Gene 2016;591(1):1–5.
Shetty YC, Patil AE, Jalgaonkar SV, Rege NN, Salgaonkar S, Teltumbde PA, et al. Intra-articular injections of ketamine and 25% dextrose improve clinical and pathological outcomes in the monosodium iodoacetate model of osteoarthritis. J Basic Clin Physiol Pharmacol 2017;28(6):543–53.
Frank E, Hung HH, Krishnan Y, Senter B, Bodick N, Grodzinsky A. Dose-dependent chondroprotective effects of triamcinolone acetonide on inflamed and injured cartilage using an in vitro model. Osteoarthritis Cartilage 2019;27(1):176–84.
Elsawy SA, Hamdy M, Ahmed MS. Intra-articular injection of hyaluronic acid for treatment of osteoarthritis knee: Comparative study to intra-articular corticosteroids. Egy Rheumatol Rehab 2017;44(4):143–6.
Ayhan E, Kesmezacar H, Akgun I. Intraarticular injections (corticosteroid, hyaluronic acid, platelet rich plasma) for the knee osteoarthritis. World J Orthop 2014;5(3):351–61.